Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin.

Kogawa, K; Muramatsu, H; Tanaka, M; Nishihori, Y; Hagiwara, S; Kuribayashi, K; Nakamura, K; Koike, K; Sakamaki, S; Niitsu, Y

Kogawa, K; Muramatsu, H; Tanaka, M; Nishihori, Y; Hagiwara, S; Kuribayashi, K; Nakamura, K; Koike, K; Sakamaki, S; Niitsu, Y.

Affiliation

Kogawa K; Fourth Department of Internal Medicine, Sapporo Medical University School of Medicine, Hokkaido, Japan.

Clin Exp Metastasis ; 17(3): 239-44, 1999 May.

Article in En | MEDLINE | ID: mdl-10432009

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Doxorubicin/therapeutic use; Free Radical Scavengers/therapeutic use; Lung Neoplasms/secondary; Neoplasm Metastasis/prevention & control; Superoxide Dismutase/therapeutic use; Animals; Cell Division/drug effects; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lung Neoplasms/drug therapy; Lung Neoplasms/pathology; Mice; Mice, Inbred BALB C; Platelet Aggregation/drug effects; Reactive Oxygen Species/metabolism; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Superoxide Dismutase / Antineoplastic Combined Chemotherapy Protocols / Doxorubicin / Free Radical Scavengers / Lung Neoplasms / Neoplasm Metastasis Limits: Animals / Humans Language: En Year: 1999 Type: Article

Search on Google

XML

PubMed Links